Leave your limits behind: Join The May 50K!
20 March 2019
This May we would like to invite you to help Kiss Goodbye to MS by signing up for our new fundraising activity – The May 50K!
This May we would like to invite you to help Kiss Goodbye to MS by signing up for our new fundraising activity – The May 50K!
MS predominately affects young women at an age when many are starting or growing their families, making treatment
Trevor Bolland tells his story of father-daughter fundraising for MS research, from the moment his beloved daughter Monique was diagnosed with MS to today.
About this episode – Gut bacteria and MS In this episode we speak to Dr Wolfgang Marx at
Researchers funded by MS Research Australia have published new findings revealing how epigenetic changes may be important in MS.
Full results of the ‘MIST’ trial have been published which compared autologous haematopoietic stem cell transplant (AHSCT) to other available MS therapies. The results confirmed that AHSCT treatment can provide a more prolonged remission for patients with very active MS compared to some other available MS therapies.
International study results show that DMTs significantly decrease the probability of converting from relapsing remitting MS to secondary progressive MS.
The results of an observational trial into AHSCT in Sydney have been released showing good results for some people with relapsing-remitting MS.
How does MS begin? There has been ongoing debate in the scientific world around the so called “outside-in” or “inside-out” question.